Aktis Oncology (NasdaqGS:AKTS) FY Earnings Call Presentation

Maximizing the Impact of Radiopharmaceuticals TD Cowen 46th Annual Healthcare Conference March 2026 1 Disclaimer Information in this presentation and the accompanying oral presentation contains forward-looking statements within the meaning of the Private Securities Litigation Act of 1995 that involve substantial risks and uncertainties about Aktis Oncology and the industry in which Aktis Oncology operates, including statements regarding the initiation, timing, progress, results and costs of Aktis Oncology's ...